BioRestorative Therapies (BRTX) Operating Leases (2019 - 2024)
BioRestorative Therapies' Operating Leases was $42,414 in Q3 2023, down 78.7% from $198,724 a year earlier and down 49.3% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Operating Leases (2019 - 2024) Analysis & Trends
At the end of FY2022, Operating Leases at BioRestorative Therapies came in at $162,317, down 46.2% from FY2021.
- Operating Leases has now declined for three consecutive years, with a three-year compound annual growth rate of -32.2% (FY2019 to FY2022).
- In earlier years, Operating Leases was $301,645 in FY2021 (-17.0%), $363,519 in FY2020 (-30.3%) and $521,890 in FY2019.
- The Q3 2023 figure marks the lowest quarterly Operating Leases in data going back to Q4 2019.
- Compared with a year earlier, Operating Leases has declined for 12 straight quarters, with an average decline of 45.9% over the last eight quarters.
- The year-over-year decline in Operating Leases has ranged between 17.0% (Q4 2021) and 78.7% (Q3 2023) over the last five years.
- Per Business Quant data, BRTX's Operating Leases in the three quarters before Q3 2023 was $83,580 (Q2 2023), $123,536 (Q1 2023) and $162,317 (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | BioRestorative Therapies | 1.36 Mn | -17.06 Mn | 15,785.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 42,414.00 |
| Jun 30, 2024 | 83,580.00 |
| Mar 31, 2024 | 123,536.00 |
| Dec 31, 2023 | 162,317.00 |
| Sep 30, 2023 | 42,414.00 |
| Jun 30, 2023 | 83,580.00 |
| Mar 31, 2023 | 123,536.00 |
| Dec 31, 2022 | 162,317.00 |
| Sep 30, 2022 | 198,724.00 |
| Jun 30, 2022 | 234,060.00 |
| Mar 31, 2022 | 268,357.00 |
| Dec 31, 2021 | 301,645.00 |
| Sep 30, 2021 | 332,755.00 |
| Jun 30, 2021 | 362,949.00 |
| Mar 31, 2021 | 392,256.00 |
| Dec 31, 2020 | 363,519.00 |
| Sep 30, 2020 | 447,142.00 |
| Jun 30, 2020 | 472,805.00 |
| Mar 31, 2020 | 497,714.00 |
| Dec 31, 2019 | 521,890.00 |
API Access
BioRestorative Therapies Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();